Loading company…
Riskpilot
← Back to search
Sign in
Get full access
NORDIC BIO GROUP AS
AS
Active
Org 979902263
Langmyrgrenda 21, 0861 Oslo
Produksjon av elektrisitet fra biobrensel · NACE 35113
Est. 1998
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2021
NOK 5K
EBITDA margin
-637.8%
+54% vs 2020
Equity ratio
-151.1%
Financial strength
Net profit 2021
NOK -260K
-274% vs 2020
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2017
0M
0%
2018
0M
0%
2019
0M
0%
2020
0M
0%
2021
Key figures
Annual report 2021
Revenue
NOK 5K
—
EBITDA
NOK -32K
+54%
Net profit
NOK -260K
-274%
Total assets
NOK 22K
-91%
Equity
NOK -34K
-115%
Employees
2
—
Company information
Legal name
NORDIC BIO GROUP AS
Org number
979902263
Legal form
Aksjeselskap
NACE code
35113 · Produksjon av elektrisitet fra biobrensel
Founded
23. april 1998
Share capital
—
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Contact
Address
Langmyrgrenda 21, 0861 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Produksjon av elektrisitet fra biobrensel
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
0M
2019
0M
2020
0M
2021
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2017
0M
2018
0M
2019
0M
2020
0M
2021
Income statement
NOK thousands
Item
2017
2018
2019
2020
2021
Revenue
0
0
0
0
5
Staff expenses
−31
−31
−28
−28
−31
EBITDA
−84
−73
−69
−70
−32
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−84
−73
−69
−70
−32
Net financials
1
9
8
0
−228
Profit before tax
−84
−63
−61
−70
−260
Tax
−0
−0
−0
−0
−0
Net profit
−84
−63
−61
−70
−260
Balance sheet
NOK thousands
Item
2017
2018
2019
2020
2021
Total assets
426
364
303
237
22
Equity
420
357
296
226
−34
Long-term debt
0
0
0
0
0
Short-term debt
6
7
7
10
56
Total debt
6
7
7
10
56
Financial ratios
5-year trend
EBITDA margin
-637.8%
This company
15.8%
Market median
-4137% vs market
2017
2021
Equity ratio
-151.1%
This company
38.2%
Market median
-496% vs market
2017
2021
Return on equity
-25996800.0%
This company
18.4%
Market median
-141287057% vs market
2017
2021
Net profit margin
-5199.4%
This company
8.1%
Market median
-64290% vs market
2017
2021
Asset turnover
0.23×
This company
1.12×
Market median
-79% vs market
2017
2021
Debt / equity
1.66×
This company
0.62×
Market median
-168% vs market
2017
2021
Annual reports & filings
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AM
Aud Marie Kevin
Deputy Member
Deputy Member
2004
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
RS
Rolf Sten Kevin
Chairman
2004
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of NORDIC BIO GROUP AS also hold positions in
0
other companies.
Person
Role here
Other companies
Aud Marie Kevin
Deputy Member
0 companies
Rolf Sten Kevin
Chairman
0 companies